Olema Pharmaceuticals, Inc. · NASDAQ:OLMA
Harmon Cyrus sold 25,000 Olema Pharmaceuticals, Inc. shares (Form 4)
Traded Jul 23 to Jul 24, 2026 · Filed Jul 27, 2026
From Jul 23 to Jul 24, 2026, Harmon Cyrus (Director) sold 25,000 Olema Pharmaceuticals, Inc. shares at an average US$11.65 for US$291K, leaving 702,770 shares. Filed Jul 27, 2026 (Form 4).
- Sold
- 25,000 shares
- Price
- US$11.65 average (US$11.58 to US$11.71)
- Value
- US$291K
- Holding after
- 702,770 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 23, 2026 | Common Stock | Sale | 12,500 | US$11.58 | 715,270 | Direct |
| Jul 24, 2026 | Common Stock | Sale | 12,500 | US$11.71 | 702,770 | Direct |
Source
Related
- Olema Pharmaceuticals, Inc.
- Harmon Cyrus
- Olema Pharmaceuticals, Inc. shareholders
- Schedule 13D/A · Bvf Partners L P · Oct 16, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities IV, L.P. · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026